Hims & Hers Health (HIMS) Total Non-Current Liabilities (2020 - 2026)

Hims & Hers Health's (HIMS) quarterly Total Non-Current Liabilities came in at $1.8 billion in Q1 2026, up 431.74% year-on-year from $340.0 million in Q1 2025, and up 12.85% quarter-over-quarter from $1.6 billion in Q4 2025.

Hims & Hers Health (HIMS) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Hims & Hers Health has disclosed Total Non-Current Liabilities across 7 years of filings, most recently posting $1.8 billion for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $1.8 billion, up 431.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 431.74% YoY), and the FY2025 annual result was $1.6 billion, up 594.06% from the prior year.
  • Total Non-Current Liabilities came in at $1.8 billion for Q1 2026 at Hims & Hers Health, up from $1.6 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.8 billion in Q1 2026 to a low of $53.8 million in Q1 2022.
  • The 5-year median for Total Non-Current Liabilities is $103.6 million (2024), against an average of $463.3 million.
  • Across the five-year window, Total Non-Current Liabilities slumped 35.02% in 2022 and jumped 1008.31% in 2025, its largest moves.
  • Hims & Hers Health's Total Non-Current Liabilities stood at $54.6 million in 2022, then soared by 78.02% to $97.1 million in 2023, then jumped by 137.63% to $230.8 million in 2024, then jumped by 594.06% to $1.6 billion in 2025, then climbed by 12.85% to $1.8 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $1.8 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 18.28 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 2.44 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.13 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 1.81 Bn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.81 Bn
Dec 31, 2025 1.60 Bn
Sep 30, 2025 1.65 Bn
Jun 30, 2025 1.31 Bn
Mar 31, 2025 340.01 Mn
Dec 31, 2024 230.82 Mn
Sep 30, 2024 162.21 Mn
Jun 30, 2024 118.51 Mn
Mar 31, 2024 103.60 Mn
Dec 31, 2023 97.14 Mn
Sep 30, 2023 85.30 Mn
Jun 30, 2023 69.81 Mn
Mar 31, 2023 59.58 Mn
Dec 31, 2022 54.57 Mn
Sep 30, 2022 71.14 Mn
Jun 30, 2022 59.40 Mn
Mar 31, 2022 53.81 Mn
Dec 31, 2021 83.97 Mn
Sep 30, 2021 63.70 Mn
Jun 30, 2021 29.24 Mn